Free Trial
NASDAQ:CBLL

CeriBell (CBLL) Stock Price, News & Analysis

CeriBell logo
$16.76 -0.37 (-2.13%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About CeriBell Stock (NASDAQ:CBLL)

Key Stats

Today's Range
$16.40
$17.22
50-Day Range
$15.85
$19.65
52-Week Range
$10.01
$32.75
Volume
75,139 shs
Average Volume
286,615 shs
Market Capitalization
$605.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.14
Consensus Rating
Buy

Company Overview

CeriBell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

CBLL MarketRank™: 

CeriBell scored higher than 49% of companies evaluated by MarketBeat, and ranked 552nd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CeriBell has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CeriBell has only been the subject of 1 research reports in the past 90 days.

  • Read more about CeriBell's stock forecast and price target.
  • Earnings Growth

    Earnings for CeriBell are expected to grow in the coming year, from ($2.46) to ($1.18) per share.

  • Price to Book Value per Share Ratio

    CeriBell has a P/B Ratio of 3.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about CeriBell's valuation and earnings.
  • Short Interest

    There is no current short interest data available for CBLL.
  • Dividend Yield

    CeriBell does not currently pay a dividend.

  • Dividend Growth

    CeriBell does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CBLL.
  • News Sentiment

    CeriBell has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for CeriBell this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    2 people have added CeriBell to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CeriBell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,895,195.00 in company stock.

  • Percentage Held by Insiders

    20.10% of the stock of CeriBell is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CeriBell's insider trading history.
Receive CBLL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CeriBell and its competitors with MarketBeat's FREE daily newsletter.

CBLL Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
CeriBell: An EEG Concern Posting Impressive Growth
See More Headlines

CBLL Stock Analysis - Frequently Asked Questions

CeriBell's stock was trading at $25.88 at the beginning of the year. Since then, CBLL stock has decreased by 35.2% and is now trading at $16.7650.

CeriBell, Inc. (NASDAQ:CBLL) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.36) EPS for the quarter, beating analysts' consensus estimates of ($0.43) by $0.07. The business had revenue of $20.49 million for the quarter, compared to analyst estimates of $19.30 million.
Read the conference call transcript
.

CeriBell (CBLL) raised $180 million in an initial public offering on Friday, October 11th 2024. The company issued 10,606,060 shares at a price of $17.00 per share.

Shares of CBLL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/08/2025
Today
7/09/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CBLL
Previous Symbol
NASDAQ:CBLL
CIK
1861107
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$36.00
Low Price Target
$30.00
Potential Upside/Downside
+87.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$65.44 million
Price / Cash Flow
N/A
Book Value
$5.34 per share
Price / Book
3.21

Miscellaneous

Free Float
28,878,000
Market Cap
$619.08 million
Optionable
N/A
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CBLL) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners